osmium has been researched along with Triple Negative Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brabec, V; Kasparkova, J; Kostrhunova, H; Novohradsky, V; Pracharova, J; Štarha, P; Trávníček, Z | 1 |
Bohic, S; Bouron, A; Carriere, M; Cloetens, P; da Silva, JC; Fus, F; Jaouen, G; Lee, HZS; Pacureanu, A; Salmain, M; Top, S; Vessières, A; Yang, Y | 1 |
2 other study(ies) available for osmium and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms | 2018 |
Intracellular Localization of an Osmocenyl-Tamoxifen Derivative in Breast Cancer Cells Revealed by Synchrotron Radiation X-ray Fluorescence Nanoimaging.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Coordination Complexes; Female; Humans; Hydrogen-Ion Concentration; Iron; Ligands; Molecular Imaging; Molecular Probes; Nanostructures; Organometallic Compounds; Osmium; Radiography; Ruthenium; Static Electricity; Synchrotrons; Tamoxifen; Triple Negative Breast Neoplasms; X-Rays | 2019 |